Medication-Assisted Treatment for Youth With Substance Use Disorders

Summary

The purpose of this open-label pilot study is to determine the tolerability and applicability of outpatient long-acting injectable naltrexone (Vivitrol) treatment in individuals age 16-25 ("older youth") with opioid use disorder. Outpatient treatment will consist of a 7-day outpatient detoxification / naltrexone induction procedure followed by 8-weeks of treatment with Vivitrol.

Timeline

Start

2015-09

Primary completion

2018-04

Completion

2018-04

Drugs

Indications